Cargando…

EXT418, a novel long‐acting ghrelin, mitigates Lewis lung carcinoma induced cachexia in mice

BACKGROUND: Ghrelin is a potential therapy for cachexia due to its orexigenic properties and anabolic effects on muscle and fat. However, its clinical use is limited by the short half‐life of active (acylated) ghrelin (~11 min in humans). EXT418 is a novel long‐acting, constitutively active ghrelin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kerr, Haiming L., Krumm, Kora, Lee, Ian (In‐gi), Anderson, Barbara, Christiani, Anthony, Strait, Lena, Breckheimer, Beatrice A., Irwin, Brynn, Jiang, Alice (Siyi), Rybachok, Artur, Chen, Amanda, Caeiro, Lucas, Dacek, Elizabeth, Hall, Daniel B., Kostyla, Caroline H., Hales, Laura M., Soliman, Tarik M., Garcia, Jose M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235874/ https://www.ncbi.nlm.nih.gov/pubmed/36942661 http://dx.doi.org/10.1002/jcsm.13211

Ejemplares similares

Growth hormone secretagogue receptor‐1a mediates ghrelin's effects on attenuating tumour‐induced loss of muscle strength but not muscle mass
por: Liu, Haiming, et al.
Publicado: (2021)

Ghrelin for cachexia
por: Akamizu, Takashi, et al.
Publicado: (2010)

THU512 Elevated Insulin Like Growth Factor Binding Protein 2 Levels Are Associated With Muscle Wasting And Increased Insulin Sensitivity In Cancer Patients
por: Caeiro, Lucas, et al.
Publicado: (2023)

Chronic Renal Failure, Cachexia, and Ghrelin
por: Laviano, A., et al.
Publicado: (2010)

Novel mechanism of ghrelin therapy for cachexia
por: Hatanaka, Michiyoshi, et al.
Publicado: (2015)

Cachexia: Pathophysiology and Ghrelin Liposomes for Nose-to-Brain Delivery
por: T. de Barros, Cecilia, et al.
Publicado: (2020)

Analysis of mutations in EXT1 and EXT2 in Brazilian patients with multiple osteochondromas
por: Santos, Savana C. L., et al.
Publicado: (2018)

Plasma Ghrelin Levels Are Associated with Anorexia but Not Cachexia in Patients with NSCLC
por: Blauwhoff-Buskermolen, Susanne, et al.
Publicado: (2017)

Mutations in the EXT1 and EXT2 genes in Spanish patients with multiple osteochondromas
por: Sarrión, P., et al.
Publicado: (2013)

MINOS: Bt 376 - 599 ext - 376 ext - AP (100)
Publicado: (1991)

Mastering Ext JS
por: Groner, Loiane
Publicado: (2015)

Learning Ext JS
por: Méndez, Carlos A, et al.
Publicado: (2015)

Ext JS in action
por: García, Jesús
Publicado: (2011)

Learning Ext JS
por: Ramsay, Colin, et al.
Publicado: (2008)

Ext JS in action
por: Garcia, Jesus, et al.
Publicado: (2014)

Ghrelin and its potential in the treatment of eating/wasting disorders and cachexia
por: Müller, Timo D., et al.
Publicado: (2010)

Rikkunshito, a ghrelin potentiator, ameliorates anorexia–cachexia syndrome
por: Fujitsuka, Naoki, et al.
Publicado: (2014)

Structure of the human heparan sulfate polymerase complex EXT1-EXT2
por: Leisico, Francisco, et al.
Publicado: (2022)

A broad spectrum of genomic changes in latinamerican patients with EXT1/EXT2-CDG
por: Delgado, M. A., et al.
Publicado: (2014)

A Review of Nutraceuticals in Cancer Cachexia
por: Caeiro, Lucas, et al.
Publicado: (2023)

Mutation spectrum of EXT1 and EXT2 in the Saudi patients with hereditary multiple exostoses
por: Al-Zayed, Zayed, et al.
Publicado: (2021)

Potentiation of ghrelin signaling attenuates cancer anorexia–cachexia and prolongs survival
por: Fujitsuka, N, et al.
Publicado: (2011)

Natural ghrelin in advanced cancer patients with cachexia, a case series
por: Blum, David, et al.
Publicado: (2021)

Practical Ext JS 4
por: Sunderaraman, Prabhu
Publicado: (2013)

Learning Ext JS 4
por: Villa, Crysfel, et al.
Publicado: (2013)

Breakpoint characterization of large deletions in EXT1 or EXT2 in 10 Multiple Osteochondromas families
por: Jennes, Ivy, et al.
Publicado: (2011)

Mutational screening of EXT1 and EXT2 genes in Polish patients with hereditary multiple exostoses
por: Jamsheer, Aleksander, et al.
Publicado: (2014)

Séminaire Bourbaki : exposés 418–435
por: Dold, A, et al.
Publicado: (1974)

Large-scale mutational analysis in the EXT1 and EXT2 genes for Japanese patients with multiple osteochondromas
por: Ishimaru, Daichi, et al.
Publicado: (2016)

Hereditary multiple osteochondromas in Jordanian patients: Mutational and immunohistochemical analysis of EXT1 and EXT2 genes
por: Mohaidat, Ziyad, et al.
Publicado: (2021)

Development of coated liposomes loaded with ghrelin for nose-to-brain delivery for the treatment of cachexia
por: Salade, Laurent, et al.
Publicado: (2017)

Practical Ext JS Projects with Gears
por: Zammetti, Frank
Publicado: (2009)

Ext GWT 20 Beginner's Guide
por: Vaughan, Daniel
Publicado: (2010)

Ext JS 4 First Look
por: Groner, Loiane
Publicado: (2012)

Loss of Function in Heparan Sulfate Elongation Genes EXT1 and EXT 2 Results in Improved Nitric Oxide Bioavailability and Endothelial Function
por: Mooij, H. L., et al.
Publicado: (2014)

Ext JS application development blueprints: develop robust and maintainable projects that exceed client expectations using Ext JS
por: Ramsay, Colin
Publicado: (2015)

Developing with Ext GWT: Enterprise RIA Development
por: Slender, Grant
Publicado: (2009)

Mutations in the heparan sulfate backbone elongating enzymes EXT1 and EXT2 have no major effect on endothelial glycocalyx and the glomerular filtration barrier
por: Khalil, Ramzi, et al.
Publicado: (2022)

RNA‐Seq detects a SAMD12‐EXT1 fusion transcript and leads to the discovery of an EXT1 deletion in a child with multiple osteochondromas
por: Oliver, Gavin R., et al.
Publicado: (2019)

Acute Toxicity and General Pharmacological Action of QGC EXT
por: Lee, Jong Mi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_dl1s8qe8it2n36vuuin66l2he4